{"id":432836,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2015-10-16] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T08:59:10.745000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-3.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Multiple additions October 16, 2015 Our file number: 15-111220-880 The purpose of this Notice of Amendment is to notify the addition of Asfotase alfa, Daclatasvir, Deoxycholic Acid, Empagliflozin, Ramucirumab, and Teduglutide to both the…","rawSnapshotUrl":"/api/snapshots/raw/432836","browseUrl":"https://replay.healtharchive.ca/job-6/20260102085910/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-3.html?wbdisable=true#ha_snapshot=432836","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}